Stockholm, 2nd of June 2026 – Virtune AB (Publ) (“Virtune”) today announces that it has completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm, Nasdaq Helsinki and Xetra (ISIN code SE0023260716). In addition to the Virtune Crypto Altcoin Index ETP, Virtune’s product portfolio includes: Virtune Bitcoin ETPVirtune Staked Ethereum ETPVirtune Stellar ETPVirtune Staked Solana ETPVirtune Staked Polkadot ETPVirtune XRP ETPVirtune Avalanche ETPVirtune Litecoin ETPVirtune Chainlink ETPVirtune Arbitrum ETPVirtune Polygon ETPVirtune Staked Cardano ETPVirtune Crypto Top 10 Index ETP SEKVirtune Crypto Top 10 Index ETP EURVirtune Crypto Altcoin Index ETP Virtune Bitcoin Prime ETPVirtune Coinbase 50 Index ETPVirtune Staked Near ETP Virtune Sui ETPVirtune Stablecoin Index ETPVirtune Bittensor...

Audiences can now experience the thrill of the catch with riveting, real-life angling stories and no-holds-barred fishing adventures MONTREAL, June 02, 2026 (GLOBE NEWSWIRE) — Stingray (TSX: RAY), the world’s leading connected streaming media company, today announced the premiere launch of its newest channel, Stingray Hooked, now available to audiences in the United States on The Roku Channel. This addition marks the very first time the anticipated channel has been introduced to viewers. Stingray Hooked invites audiences to take to the open water with riveting footage of no-holds-barred fishing expeditions. These real-life angling stories and raucous wrangling matches will keep viewers on the edge of their seats, offering an unparalleled look into the thrilling world of competitive and recreational fishing. “We are incredibly...

MONTREAL, June 02, 2026 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) today announced that Eric Vachon, President & Chief Executive Officer and Silvana Travaglini, Senior Vice-President & Chief Financial Officer will participate in the 2026 National Bank Annual Quebec Conference in Toronto, Ontario, on Wednesday, June 3, 2026. Stella-Jones is scheduled to host a fireside chat at the event at 11:00 a.m. (EDT). Management will host institutional investor meetings at the Conference, which can be arranged by contacting your National Bank representative or dgalison@stella-jones.com. About Stella-Jones Stella-Jones Inc. (TSX: SJ) is a leading North American manufacturer of products focused on supporting infrastructure essential to the electrical distribution and transmission network, and the...

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to provide shareholders and stakeholders with an update on the Company’s project acceleration initiatives and ongoing development activities at the Tanbreez Rare Earth Project in Greenland. The Company continues to advance its strategic acceleration plan, with significant progress achieved across infrastructure development, field operations, geological programs, and logistics designed to support the next phase of project advancement. Tanbreez Project Development Update Construction activities continue to progress at the Tanbreez Project, with infrastructure works advancing according to plan. Footings for the project’s pilot plant headquarters...

CHICAGO, June 02, 2026 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that its founder and CEO Vlad Vitoc, M.D. and Director Stan V. Smith, Ph.D. have increased their ownership positions through open market purchases. Approximately 72,700 shares of MAIA common stock were purchased by Dr. Vitoc on June 6, 2026, at an average common stock price of $1.3877. Approximately 75,000 shares of MAIA common stock were purchased by Dr. Smith on June 6, 2026, at an average common stock price of $1.336. “Our continuing investments underscore our strong confidence in the telomere-targeting immuno-oncology platform we’ve established,” said Dr. Vitoc. “As the ateganosine program advances...